← Open Payments lookup

VICTORIA MOJIBOLA: Open Payments

NPI 1841789146 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,146 in 76 payments from 10 companies in 2025. Trend: 2023 $1,285 · 2024 $1,427 · 2025 $2,146

Food & beverage: $2,018Education: $128
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.20$728
Vanda Pharmaceuticals Inc.8$242
ABBVIE INC.11$235
E.R. Squibb & Sons, L.L.C.5$185
Teva Pharmaceuticals USA, Inc.4$162
Janssen Pharmaceuticals, Inc8$154
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$139
Supernus Pharmaceuticals, Inc.7$124
Alkermes, Inc.4$93
Otsuka America Pharmaceutical, Inc.3$85

Products named: INGREZZA, VRAYLAR, COBENFY, HETLIOZ, CAPLYTA, Qelbree, INVEGA SUSTENNA, FANAPT.

Industry payments across MD — which companies pay providers there.